Skip to main content
. 2016 Aug 1;3:160057. doi: 10.1038/sdata.2016.57

Table 2. Summary of crystallization conditions.

Receptor/ligand Buffer Precipitant Salt Additive
5-HT2B/ergotamine 0.1 M Tris pH 8.0 30% v/v PEG 400 20–80 mM MgCl2
SMO/cyclopamine 0.1 M Hepes pH 7.0 30% v/v PEG 400 100 mM NaCl
δ-OR/DIPP-NH2 0.1 M MES pH 6.0 30-32% v/v PEG 400 50–180 mM Li citrate
AT1R/ZD7155 0.1 M Na Citrate pH 5.0 28% v/v PEG 400 450 mM NH4H2PO4 4% v/v DMSO